retatrutide clinical trials brazil New Phase 3 data just dropped 👀 Eli Lilly's trial reported average weight loss approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats Retatrutide: A Promising Option for

Frequency of hypoglycemia and its significance in chronic kidney disease

Olive oil consumption and risk of CHD and/or stroke: A meta-analysis of case-control, cohort and intervention studies

When you take semaglutide or tirzepatide, these medications activate those receptors to reduce appetite and slow digestion

GLP-1 drugs may be prescribed for the following conditions as per American Diabetes Association/European Association for the Study of Diabetes (ADA/EASD) 2025 guidelines 11 : Primary glycaemic indication: GLP-1 RAs are recommended for adults with type 2 diabetes who have not reached their individualised A1C targets (typically when A1C is 1.5% above the agreed glycaemic goal) despite lifestyle measures and foundational therapy such as metformin